Evidence map›Paper›PMID 26409279›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis.

Mark Patrick Nicol, Devasena Gnanashanmugam, Renee Browning, Eleanor S Click, Luis E Cuevas, Anne Detjen, Steve M Graham, Michael Levin, Mamodikoe Makhene, Payam Nahid and 7 more

Open access · bronzeAbstract readConsensus Development Conference, NIH
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tuberculosis in Children.Pediatric clinics of North America · 2017
    Review
  15. Article
  16. Assessment of treatment response in tuberculosis.Expert review of respiratory medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 6 countries.

Mark Patrick NicolDivision of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service of South Africa.
Devasena GnanashanmugamNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
Renee BrowningNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
Eleanor S ClickDivision of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia.
Luis E CuevasDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, United Kingdom.
Anne DetjenInternational Union Against Tuberculosis and Lung Disease, Paris, France.
Steve M GrahamInternational Union Against Tuberculosis and Lung Disease, Paris, France Centre for International Child Health, University of Melbourne, and Department of Paediatrics and Murdoch Childrens Research Institute, Royal Children's Hospital Burnet Institute, Melbourne, Australia.
Michael LevinDepartment of Pediatrics, Imperial College, London, United Kingdom.
Mamodikoe MakheneNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
Payam NahidPulmonary and Critical Care Medicine, University of California, San Francisco.
Carlos M Perez-VelezDivision of Infectious Diseases, Banner-University Medical Center Phoenix, University of Arizona College of Medicine.
Klaus ReitherSwiss Tropical and Public Health Institute, University of Basel, Switzerland.
Rinn SongDivision of Infectious Diseases, Boston Children's Hospital Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Hans M L SpiegelHJF-DAIDS, a Division of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Contractor to National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Carol WorrellNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
Heather J ZarDepartment of Paediatrics and Child Health, Red Cross Children's Hospital and Medical Research Council Unit on Child and Adolescent Health, University of Cape Town.
Gerhard WalzlDepartment of Science and Technology and National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research/Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.
National Institute of Allergy and Infectious Diseases · USBanner - University Medical Center Phoenix · USBoston Children's Hospital · USCenters for Disease Control and Prevention · USImperial College London · GBInternational Union Against Tuberculosis and Lung Disease · FRLiverpool School of Tropical Medicine · GBNational Health Laboratory Service · ZARoyal Children's Hospital · AUStellenbosch University · ZAUniversity of Basel · CHUniversity of California, San Francisco · USUniversity of Cape Town · ZA

Funding

NIAID NIH HHS HHSN272200800014CPHS HHS HHSN272200800014C
6 · The paper itself

Abstract

Childhood tuberculosis contributes significantly to the global tuberculosis disease burden but remains challenging to diagnose due to inadequate methods of pathogen detection in paucibacillary pediatric samples and lack of a child-specific host biomarker to identify disease. Accurately diagnosing tuberculosis in children is required to improve case detection, surveillance, healthcare delivery, and effective advocacy. In May 2014, the National Institutes of Health convened a workshop including researchers in the field to delineate priorities to address this research gap. This blueprint describes the consensus from the workshop, identifies critical research steps to advance this field, and aims to catalyze efforts toward harmonization and collaboration in this area.

Indexed as

BiomarkersBiomedical ResearchTuberculosisBiological Specimen BanksChildDelivery of Health CareHumansNational Institutes of Health (U.S.)PediatricsSpecimen HandlingUnited StatesBiomarkersbiomarkerblueprintchildrendiagnosistuberculosis

Identifiers

PMID26409279
PMCPMC4583573
OpenAlexW2103268981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.